These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5728168)

  • 21. [A new preparative method of 6-substituted-3-amino-1,2,4-triazines].
    Maeda T; Saidawa I
    Yakugaku Zasshi; 1967 Dec; 87(12):1509-13. PubMed ID: 5628361
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synthesis and biochemical properties of substituted phenoxy- and anilino-1,3,5-triazines].
    Kreutzberger A; Richter B
    Arch Pharm (Weinheim); 1983 Jul; 316(7):577-81. PubMed ID: 6615171
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers.
    Ma X; Poon TY; Wong PT; Chui WK
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5644-7. PubMed ID: 19716698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines.
    Srinivas K; Srinivas U; Rao VJ; Bhanuprakash K; Kishore KH; Murty US
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1121-3. PubMed ID: 15686925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Aryl-4,6-diamino-1,2-dihydrotriazine as antimalarial agent: a new synthetic route.
    Kidwai M; Mothsra P; Mohan R; Biswas S
    Bioorg Med Chem Lett; 2005 Feb; 15(4):915-7. PubMed ID: 15686886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analgesic, anti-inflammatory and toxic effects of 3-substituted benzo-1,2,4-triazines].
    Metzner J; Paintz M
    Pharmazie; 1981 Oct; 36(10):714. PubMed ID: 6975947
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of the inhibition of bovine and murine leukemia dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-X-phenyl)-s-triazines.
    Guo ZR; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    Mol Pharmacol; 1981 Nov; 20(3):649-56. PubMed ID: 7329407
    [No Abstract]   [Full Text] [Related]  

  • 28. Direct oxidative coupling of amidine hydrochlorides and methylarenes: TBHP-mediated synthesis of substituted 1,3,5-triazines under metal-free conditions.
    Guo W
    Org Biomol Chem; 2015 Nov; 13(41):10285-9. PubMed ID: 26411699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antibacterial activity of various substituted s-triazines.
    Srinivas K; Srinivas U; Bhanuprakash K; Harakishore K; Murthy US; Rao VJ
    Eur J Med Chem; 2006 Nov; 41(11):1240-6. PubMed ID: 16815597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diamino-1,3,5-triazine derivatives. IV. Synthesis and hypoglycemic properties of various 6-amino-1,2-dihydro-4-(5-methyl-2-pyrazoline)-1,3,5-triazine derivatives].
    Gajewski F; Rogulski J; Pacanis A
    Acta Pol Pharm; 1983; 40(5-6):537-44. PubMed ID: 6677069
    [No Abstract]   [Full Text] [Related]  

  • 31. [Derivatives of diamino-1,3,5-triazine. I. Synthesis of some derivatives of 2-amino-4-(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine with potential hypoglycemic effect].
    Brzozowski Z; Kozakiewicz I
    Acta Pol Pharm; 1980; 37(6):601-5. PubMed ID: 7293804
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on triazines as future oral antidiabetics].
    Suter H; Zutter H
    Helv Chim Acta; 1965 Dec; 48(8):1940-4. PubMed ID: 5848009
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diamino-1,3,5-triazine derivatives. V. Synthesis and hypoglycemic properties of various 6-amino-1,2-dihydro-4(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine derivatives].
    Gajewski F; Kamiński Z; Pacanis A; Rogulski J
    Acta Pol Pharm; 1983; 40(5-6):545-9. PubMed ID: 6677070
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and biological evaluation of substituted 1,2,3-benzotriazines and pyrido[3,2-d]-1,2,3-triazines as inhibitors of vascular endothelial growth factor receptor-2.
    Zhao XW; Liu D; Luan SL; Hu GD; Lv JL; Jing YK; Zhao LX
    Bioorg Med Chem; 2013 Dec; 21(24):7807-15. PubMed ID: 24189187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives.
    Saczewski F; Bułakowska A; Bednarski P; Grunert R
    Eur J Med Chem; 2006 Feb; 41(2):219-25. PubMed ID: 16377034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel orthogonal strategy toward solid-phase synthesis of 1,3,5-substituted triazines.
    Bork JT; Lee JW; Khersonsky SM; Moon HS; Chang YT
    Org Lett; 2003 Jan; 5(2):117-20. PubMed ID: 12529119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Derivatives of diamino-1,3,5-triazine. II. Synthesis of some derivative of 2-amino-4-(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine with potential hypoglycemic effect].
    Brzozowski Z; Kozakiewicz I; Pomarnacka E; Kamiński Z
    Acta Pol Pharm; 1980; 37(6):607-13. PubMed ID: 7293805
    [No Abstract]   [Full Text] [Related]  

  • 38. Some substituted imidazo[1,2-b] [1,2,4]triazines and 8H-pyrimido[1,2-b] [1,2,4]triazin-8-ones as potential antineoplastic agents.
    Labouta IM; Soliman FS; Kassem MG
    Pharmazie; 1986 Nov; 41(11):812-3. PubMed ID: 3562515
    [No Abstract]   [Full Text] [Related]  

  • 39. 2-Hydroxy-4,6-diamino-[1,3,5]triazines: a novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors.
    Baindur N; Chadha N; Brandt BM; Asgari D; Patch RJ; Schalk-Hihi C; Carver TE; Petrounia IP; Baumann CA; Ott H; Manthey C; Springer BA; Player MR
    J Med Chem; 2005 Mar; 48(6):1717-20. PubMed ID: 15771417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diamino-1,3,5-triazine derivatives. VI. Synthesis and hypoglycemic properties of various 6-amino-2-arylo-1,2-dihydro-4-3(3,5,5-trimethylo-2-pyra zolino)-1,3,5-t riazine].
    Gajewski F; Pacanis A; Rogulski J
    Acta Pol Pharm; 1984; 41(1):1-4. PubMed ID: 6496132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.